Home LiteratureArticle Details
PMID: 2492263 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Separate and combined effects of recombinant interleukin-1 alpha and gamma interferon on antibacterial resistance.

Infection and immunity ·Vol. 57 ·No. 2 ·1989-02-00 ·Pages 553-8

Kurtz RS, Young KM, Czuprynski CJ

Abstract

Our laboratory has previously reported that administration of murine recombinant interleukin 1 alpha (rIL-1 alpha) substantially enhanced the resistance of mice to Listeria monocytogenes infection. Other investigators have reported that gamma interferon (IFN-gamma) plays a pivotal role in antilisteria resistance. In the present study, we have defined doses of human rIL-1 alpha that enhanced the antilisteria resistance of mice. We then addressed the possibility that combined immunotherapy with rIL-1 alpha and recombinant IFN-gamma (rIFN-gamma) might result in an additive or synergistic enhancement of antibacterial resistance. Simultaneous administration of rIL-1 alpha and rIFN-gamma enhanced antilisteria resistance (at 3 days after infection) to a greater extent than did either cytokine alone, although the results did not imply a synergistic action between the two cytokines. Experiments which examined the effects of the timing of cytokine administration indicated that maximal protection was observed when rIL-1 alpha and rIFN-gamma were administered together concomitantly with the L. monocytogenes challenge. When we compared the separate and combined protective effects of rIL-1 alpha and rIFN-gamma throughout the course of a primary L. monocytogenes infection, we observed an additive effect of the two cytokines only at 3 days after challenge, the time at which the peak bacterial burden occurs in the spleens and livers of infected mice. Histopathological comparisons of livers and spleens from cytokine-treated and control listeria-infected mice verified that cytokine treatment reduced the severity of tissue damage in cytokine-treated listeria-infected mice. In an attempt to provide a potential mechanism for the protective effects of rIL-1 alpha and rIFN-gamma administration, we compared levels of colony-stimulating activity in sera from cytokine-treated and control listeria-infected mice. The highest levels of colony-stimulating activity were detected in sera from control listeria-infected mice; somewhat lower levels were found in sera from listeria-infected mice that received rIL-1 alpha and rIFN-gamma either alone or in combination.

MeSH Terms
Animals Colony-Stimulating Factors/blood Dose-Response Relationship, Immunologic Drug Administration Schedule Drug Synergism Drug Therapy, Combination Humans Immunity, Innate/drug effects Interferon-gamma/administration & dosage Interleukin-1/administration & dosage Listeriosis/blood,immunology,pathology Liver/pathology Male Mice Recombinant Proteins
Chemicals
Colony-Stimulating Factors Interleukin-1 Recombinant Proteins Interferon-gamma
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Kurtz R S
Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison 53706.
Young K M
Czuprynski C J
References (31)
31 references, click to expand
  1. Regulation of macrophage populations. I. Preferential induction of Ia-rich peritoneal exudates by immunologic stimuli.
    J Immunol. 1980 Mar;124(3):1426-32 PMID: 6766974
  2. Effects of murine recombinant interleukin 1 alpha on the host response to bacterial infection.
    J Immunol. 1988 Feb 1;140(3):962-8 PMID: 2448381
  3. Killing of Listeria monocytogenes by inflammatory neutrophils and mononuclear phagocytes from immune and nonimmune mice.
    J Leukoc Biol. 1984 Feb;35(2):193-208 PMID: 6423748
  4. Attempts to characterize the T-cell population and lymphokine involved in the activation of macrophage oxygen metabolism in murine listeriosis.
    Cell Immunol. 1984 Oct 15;88(2):545-50 PMID: 6435889
  5. Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon.
    Eur J Immunol. 1984 Oct;14(10):964-7 PMID: 6436036
  6. Genetically determined resistance to listeriosis is associated with increased accumulation of inflammatory neutrophils and macrophages which have enhanced listericidal activity.
    Immunology. 1985 Jul;55(3):511-8 PMID: 4018836
  7. Effect of Listeria monocytogenes infection on serum levels of colony-stimulating factor and number of progenitor cells in immune and nonimmune mice.
    Infect Immun. 1985 Aug;49(2):325-8 PMID: 3926646
  8. A one-plate assay for macrophage bactericidal activity.
    J Immunol Methods. 1985 Sep 3;82(1):131-40 PMID: 3928761
  9. Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection.
    Proc Natl Acad Sci U S A. 1985 Nov;82(21):7404-8 PMID: 3933006
  10. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors.
    Blood. 1986 Feb;67(2):257-67 PMID: 3002522
  11. Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor.
    J Immunol. 1986 Apr 1;136(7):2441-4 PMID: 3005410
  12. Augmented induction of interferons during Listeria monocytogenes infection.
    J Infect Dis. 1986 May;153(5):960-9 PMID: 3084667
  13. Induction by immunomodulatory agents of a macrophage antigen recognized by monoclonal antibody 158.2 and correlation with macrophage function.
    Cell Immunol. 1985 Nov;96(1):113-25 PMID: 3013425
  14. Colony-forming cells and colony-stimulating activity during listeriosis in genetically resistant or susceptible mice.
    Cell Immunol. 1986 Feb;97(2):227-37 PMID: 3488827
  15. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1.
    Nature. 1986 Sep 4-10;323(6083):86-9 PMID: 3092113
  16. Peritoneal macrophages exposed to purified macrophage colony-stimulating factor (M-CSF) suppress mitogen- and antigen-stimulated lymphocyte proliferation.
    J Immunol. 1986 Nov 1;137(9):2768-73 PMID: 3489777
  17. Interleukin 1 stimulates endothelial cells to release multilineage human colony-stimulating activity.
    J Immunol. 1987 Mar 15;138(6):1772-8 PMID: 3493286
  18. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.
    Lab Invest. 1987 Mar;56(3):234-48 PMID: 3029503
  19. Induction of colony stimulating factor in vivo by recombinant interleukin 1 alpha and recombinant tumor necrosis factor alpha 1.
    J Immunol. 1987 Apr 1;138(7):2143-8 PMID: 3494061
  20. Tumour necrosis factor. Polypeptide mediator network.
    Nature. 1987 Mar 26-Apr 1;326(6111):330-1 PMID: 3494200
  21. Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1a.
    Infect Immun. 1987 Jun;55(6):1436-40 PMID: 3553002
  22. Interleukin 1-driven secretion of interleukin 2 is highly temperature-dependent.
    J Immunol. 1987 Jun 1;138(11):3808-11 PMID: 3495573
  23. Interferon gamma and lymphotoxin or tumor necrosis factor act synergistically to induce macrophage killing of tumor cells and schistosomula of Schistosoma mansoni.
    J Exp Med. 1987 Aug 1;166(2):589-94 PMID: 3110355
  24. Recombinant murine interleukin-1 alpha enhancement of nonspecific antibacterial resistance.
    Infect Immun. 1987 Sep;55(9):2061-5 PMID: 3497878
  25. Inability of recombinant interferon-gamma to activate the antibacterial activity of mouse peritoneal macrophages against Listeria monocytogenes and Salmonella typhimurium.
    J Immunol. 1987 Sep 1;139(5):1673-8 PMID: 2957433
  26. Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice.
    Infect Immun. 1987 Nov;55(11):2715-20 PMID: 2444540
  27. Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs.
    Infect Immun. 1988 Jan;56(1):247-51 PMID: 3257205
  28. Production of tumor necrosis factor during murine listeriosis.
    J Immunol. 1987 Dec 15;139(12):4225-31 PMID: 3693903
  29. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor.
    J Immunol. 1988 Jan 1;140(1):108-11 PMID: 2447166
  30. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    J Immunol. 1988 Jan 1;140(1):112-9 PMID: 3275716
  31. Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines.
    J Immunol. 1983 Aug;131(2):788-93 PMID: 6408189
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1989-02-00
Pages
553-8
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC313132
Subset
IM
Grants
NIAID NIH HHS · R01-AI21343 · United States
NIAID NIH HHS · R29-AI24432 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com